1. Introduction
1.1 Business Market Insights Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Market Insights
2.2 Market Attractiveness
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Hypothesis formulation:
- 3.2.2 Macro-economic factor analysis:
- 3.2.3 Developing base number:
- 3.2.4 Data Triangulation:
- 3.2.5 Country level data:
4. North America Irritable Bowel Syndrome (IBS) Diagnostics Market Landscape
4.1 Market Overview
4.2 Porter's Five Forces Analysis
- 4.2.1 Bargaining Power of Suppliers
- 4.2.2 Bargaining Power of Buyers
- 4.2.3 Threat of New Entrants
- 4.2.4 Competitive Rivalry
- 4.2.5 Threat of Substitutes
4.3 Ecosystem Analysis
- 4.3.1 Raw Material Suppliers
- 4.3.2 Manufacturers
- 4.3.3 Distributors/Suppliers
- 4.3.4 End Users
5. North America Irritable Bowel Syndrome (IBS) Diagnostics Market – Key Market Dynamics
5.1 Growth Drivers
- 5.1.1 Increase in bowel's disease prevalence
- 5.1.2 Growth in demand for personalized therapeutics
5.2 Market Opportunities
- 5.2.1 Expansion in chronic disease management
- 5.2.2 Growth in the need for innovative treatments for bowel's disease
5.3 Future Trends
- 5.3.1 Increasing focus on precision medicine
- 5.3.2 Growth in advanced therapeutics for inflammatory bowel diseases
5.4 Impact of Drivers and Restraints
6. North America Irritable Bowel Syndrome (IBS) Diagnostics Market Regional Analysis
6.1 North America Irritable Bowel Syndrome (IBS) Diagnostics Market Overview
6.2 North America Irritable Bowel Syndrome (IBS) Diagnostics Market Revenue 2018-2028 (US$ Million)
6.3 North America Irritable Bowel Syndrome (IBS) Diagnostics Market Forecast Analysis
7. North America Irritable Bowel Syndrome (IBS) Diagnostics Market Analysis – by Diagnosis
7.1 Laboratory Tests
- 7.1.1 Overview
- 7.1.2 Laboratory Tests: North America Irritable Bowel Syndrome (IBS) Diagnostics Market – Revenue and Forecast to 2031 (US$ Million)
7.2 Imaging Tests
- 7.2.1 Overview
- 7.2.2 Imaging Tests: North America Irritable Bowel Syndrome (IBS) Diagnostics Market – Revenue and Forecast to 2031 (US$ Million)
8. North America Irritable Bowel Syndrome (IBS) Diagnostics Market Analysis – by Indication
8.1 Pain and Cramping
- 8.1.1 Overview
- 8.1.2 Pain and Cramping: North America Irritable Bowel Syndrome (IBS) Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
8.2 Diarrhea
- 8.2.1 Overview
- 8.2.2 Diarrhea: North America Irritable Bowel Syndrome (IBS) Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
8.3 Constipation
- 8.3.1 Overview
- 8.3.2 Constipation: North America Irritable Bowel Syndrome (IBS) Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
8.4 Alternating Constipation & Diarrhea
- 8.4.1 Overview
- 8.4.2 Alternating Constipation & Diarrhea : North America Irritable Bowel Syndrome (IBS) Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
9. North America Irritable Bowel Syndrome (IBS) Diagnostics Market – North America Analysis
9.1 North America
- 9.1.1 North America Irritable Bowel Syndrome (IBS) Diagnostics Market Breakdown, by Key
Country, 2021 and 2028 (%)
- 9.1.1.1 North America Irritable Bowel Syndrome (IBS) Diagnostics Market – Revenue and
Forecast Analysis – by Country
- 9.1.1.1 US:
North America Irritable Bowel Syndrome (IBS) Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
- 9.1.1.1.1 US: North America Irritable Bowel Syndrome (IBS) Diagnostics Market Breakdown, by Diagnosis
- 9.1.1.1.2 US: North America Irritable Bowel Syndrome (IBS) Diagnostics Market Breakdown, by Indication
- 9.1.1.2 Canada:
North America Irritable Bowel Syndrome (IBS) Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
- 9.1.1.2.1 Canada: North America Irritable Bowel Syndrome (IBS) Diagnostics Market Breakdown, by Diagnosis
- 9.1.1.2.2 Canada: North America Irritable Bowel Syndrome (IBS) Diagnostics Market Breakdown, by Indication
- 9.1.1.3 Mexico :
North America Irritable Bowel Syndrome (IBS) Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
- 9.1.1.3.1 Mexico : North America Irritable Bowel Syndrome (IBS) Diagnostics Market Breakdown, by Diagnosis
- 9.1.1.3.2 Mexico : North America Irritable Bowel Syndrome (IBS) Diagnostics Market Breakdown, by Indication
10. Competitive Landscape
10.1 Heat Map Analysis
10.2 Company Positioning and Concentration
11. North America Irritable Bowel Syndrome (IBS) Diagnostics Market Industry Landscape
11.1 Overview
11.2 Mergers and Acquisitions
11.3 Agreements, Collaborations, and Joint Ventures
11.4 New Product Launches
11.5 Expansions and Other Strategic Developments
12. Company Profiles
12.1 Commonwealth Diagnostics International
- 12.1.1 Key Facts
- 12.1.2 Business Description
- 12.1.3 Products and Services
- 12.1.4 Financial Overview
- 12.1.5 SWOT Analysis
- 12.1.6 Key Developments
12.2 Genova Diagnostics
- 12.2.1 Key Facts
- 12.2.2 Business Description
- 12.2.3 Products and Services
- 12.2.4 Financial Overview
- 12.2.5 SWOT Analysis
- 12.2.6 Key Developments
12.3 Gemelli Biotech
- 12.3.1 Key Facts
- 12.3.2 Business Description
- 12.3.3 Products and Services
- 12.3.4 Financial Overview
- 12.3.5 SWOT Analysis
- 12.3.6 Key Developments
12.4 Prometheus Laboratories
- 12.4.1 Key Facts
- 12.4.2 Business Description
- 12.4.3 Products and Services
- 12.4.4 Financial Overview
- 12.4.5 SWOT Analysis
- 12.4.6 Key Developments
12.5 Inova Diagnostics, Inc
- 12.5.1 Key Facts
- 12.5.2 Business Description
- 12.5.3 Products and Services
- 12.5.4 Financial Overview
- 12.5.5 SWOT Analysis
- 12.5.6 Key Developments
12.6 Biohit Oyj
- 12.6.1 Key Facts
- 12.6.2 Business Description
- 12.6.3 Products and Services
- 12.6.4 Financial Overview
- 12.6.5 SWOT Analysis
- 12.6.6 Key Developments
12.7 Aerodiagnostics, LLC.
- 12.7.1 Key Facts
- 12.7.2 Business Description
- 12.7.3 Products and Services
- 12.7.4 Financial Overview
- 12.7.5 SWOT Analysis
- 12.7.6 Key Developments
12.8 Metabolic Solutions, Inc
- 12.8.1 Key Facts
- 12.8.2 Business Description
- 12.8.3 Products and Services
- 12.8.4 Financial Overview
- 12.8.5 SWOT Analysis
- 12.8.6 Key Developments
12.9 Sysmex Corporation (Sysmex Europe GmbH)
- 12.9.1 Key Facts
- 12.9.2 Business Description
- 12.9.3 Products and Services
- 12.9.4 Financial Overview
- 12.9.5 SWOT Analysis
- 12.9.6 Key Developments
12.10 BÜHLMANN Laboratories AG
- 12.10.1 Key Facts
- 12.10.2 Business Description
- 12.10.3 Products and Services
- 12.10.4 Financial Overview
- 12.10.5 SWOT Analysis
- 12.10.6 Key Developments
13. Appendix
13.1 About Business Market Insights
Get Free Sample For North America Irritable Bowel Syndrome (IBS) Diagnostics Market
